SHANGHAI PHARMACEUTICALS HOLDING CO., LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.85 CNY | +0.22% |
|
+0.34% | +6.69% |
| Sales 2024 * | 289B 39.85B 3,323B | Sales 2025 * | 317B 43.77B 3,649B | Capitalization | 59.33B 8.19B 683B |
|---|---|---|---|---|---|
| Net income 2024 * | 5.18B 715M 59.63B | Net income 2025 * | 5.85B 808M 67.34B | EV / Sales 2024 * | 0.27 x |
| Net Debt 2024 * | 18.42B 2.54B 212B | Net Debt 2025 * | 19.41B 2.68B 223B | EV / Sales 2025 * | 0.25 x |
| P/E ratio 2024 * |
12.4
x | P/E ratio 2025 * |
10.9
x | Employees | 48,164 |
| Yield 2024 * |
3.35% | Yield 2025 * |
3.77% | Free-Float | 38.5% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 day | +0.22% | ||
| 1 week | +0.34% | ||
| Current month | +5.43% | ||
| 1 month | +5.00% | ||
| 3 months | +5.31% | ||
| 6 months | +4.51% | ||
| Current year | +6.69% |
1 week
17.48
18.08
1 month
16.3718.08
Current year
15.3618.81
1 year
15.3623.98
3 years
15.3628.64
5 years
15.3628.64
10 years
11.6432.10
| Managers | Title | Age | Since |
|---|---|---|---|
Yong Zhong Li
PSD | President | 54 | 27/19/27 |
Bo Shen
PSD | President | 51 | 05/13/05 |
Ye Lu
IRC | Investor Relations Contact | 35 | 01/16/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Bo Shen
PSD | President | 51 | 05/13/05 |
Yong Zhong Li
PSD | President | 54 | 27/19/27 |
Manson Fok
BRD | Director/Board Member | 67 | 27/19/27 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.86% | 2 M€ | -16.59% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 17.85 | +0.22% | 9,192,998 |
| 25/24/25 | 17.81 | +0.34% | 8,107,485 |
| 24/24/24 | 17.75 | +0.85% | 9,659,795 |
| 23/24/23 | 17.6 | -1.12% | 9,523,350 |
| 22/24/22 | 17.8 | +0.06% | 11,801,750 |
End-of-day quote Shanghai S.E., April 26, 2024
More quotes
Shanghai Pharmaceuticals Holding Co Ltd is a China-based company principally engaged in pharmaceutical industry, distribution and retail business. The Company's products include innovative drugs, chemical drugs, traditional Chinese medicines and rare disease drugs. The Company's products are mainly used in the cardiovascular system, digestive tract and metabolism, systemic anti-infection, central nervous system, anti-tumor and immunomodulators, musculoskeletal system and respiratory system. In addition, the Company also provides medical logistics and warehousing services. The Company distributes its products both in the domestic market and to overseas markets.
Sector
Pharmaceuticals
Calendar
29/08/2024
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
17.85
CNY
Average target price
20.78
CNY
Spread / Average Target
+16.42%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +6.69% | 8.19B | |
| +17.35% | 71.39B | |
| +5.38% | 8.59B | |
| -20.96% | 7.91B | |
| +0.49% | 4.54B | |
| +17.12% | 4.31B | |
| -3.38% | 3.93B | |
| -2.61% | 3.86B | |
| +22.08% | 3.64B | |
| +7.96% | 3.29B |
- Stock Market
- Equities
- 601607 Stock
